This Week in Virology26 Aug 2023

TWiV 1038: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses modeling poliovirus transmission and responses in New York State, FDA approves first vaccine for pregnant individuals to prevent RSV in infants, prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, Nirmatrelvir resistance – de novo E166V/L50V mutations in an immunocompromised patient treated with prolonged nirmatrelvir/ritonavir monotherapy leading to clinical and virological treatment failure, incidence of new-onset hypertension post–COVID-19: comparison with influenza, and post-acute sequelae of COVID-19 at 2 years.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Modeling poliovirus transmission and responses in New York State (JID)
FDA approves first vaccine for pregnant individuals to prevent RSV in infants (FDA)
Prevention and control of seasonal influenza with vaccines (CDC)
De novo E166V/L50V mutations in an immunocompromised patient treated with nirmatrelvir/ritonavir (CID)
Incidence of new-onset hypertension post–COVID-19 (Hypertension)
Postacute sequelae of COVID-19 at 2 years (Nature Medicine)
Contribute to our Floating Doctors fundraiser at PWB
Letters read on TWiV 1038
Dr. Griffin's COVID treatment summary (pdf)
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1371)

TWiV Special: Albert Sabin with Karen Torghele

Vincent speaks with Karen Torghele about her recently published biography of polio vaccine pioneer Albert Sabin, the first ever written. Host: Vincent Racaniello Guest: Karen Torghele Subscribe (free)...

29 Jun 1h 10min

TWiV 1335: TldR, bacterial hot rods and nullifying norovirus

TWiV explains research showing how temperate phages enhance bacterial host fitness via RNA-guided flagellar remodelling, and that IgA antibody is necessary and sufficient to prevent norovirus infectio...

28 Jun 1h 55min

TWiV 1334: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello discuss the global economic burden of infectious disease, restoring trust in vaccinology, the Legionnaires outbreak in Harlem, new ...

27 Jun 31min

TWiV 1334: Clinical update with Dr. Daniel Griffin

27 Jun 31min

TWiV 1333: STING like a nanoparticle, float like HIV

TWiV explains research showing how HIV-1 signalling remodels nuclear pores to licence infection, and development of STING agonist nanoparticles to enable coordinated mucosal-systemic immunity for dura...

21 Jun 1h 54min

TWiV Special: Ebola virus and Andes virus with John Dye

Vincent travels to ASM Microbe in Washington DC to speak with John Dye of the United States Army Medical Research Institute of Infectious Diseases about the recent outbreaks of Bundibugyo ebolavirus i...

20 Jun 57min

TWiV 1332: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Daniel Griffin and Vincent Racaniello express concern about vaccine policy and ACIP, scaling back of the CDC's role in global public health, shingles vaccine and dement...

20 Jun 54min

TWiV 1331: A drug for cervical cancer

TWiV explains research showing that dairy cows are infected with low doses of influenza A(H5N1) and do not transmit efficiently to other animals, and covalent inhibitors of human papillomavirus type 1...

14 Jun 1h 58min